The release of endothelium-derived relaxing factor via alpha 2-adrenergic receptor activation is specifically mediated by Gi alpha 2

J Biol Chem. 1993 Sep 15;268(26):19528-33.

Abstract

The purpose of this study is to determine which pertussis toxin-sensitive guanine nucleotide-binding protein (Gi) mediates alpha 2-adrenergic receptor stimulation of endothelium-derived relaxing factor (EDRF) release. Bovine aortic endothelial cells were treated with pertussis toxin (0-100 ng/ml) for 16 h and stimulated with an alpha 2-adrenergic receptor agonist, UK14304, to release EDRF in a bioassay system. Pertussis toxin produced a concentration-dependent decrease in EDRF release with maximal inhibition (80%) occurring at 5 ng/ml. This correlated with a decrease in receptor-G protein coupling as measured by 87% loss of high affinity agonist binding sites and 94% decrease in agonist-stimulated GTPase activity. Immunoprecipitation of [32P]NAD-ribosylated membranes using specific Gi protein antisera demonstrated that complete ADP-ribosylation of Gi alpha 2 occurred at 5 ng/ml compared to 30 ng/ml for Gi alpha 3. When bovine aortic endothelial cell membranes were treated with carboxyl terminus-directed antisera to Gi alpha 2 (P4) and Gi alpha 3 (EC), the P4 antisera abolished 86% of the high affinity agonist binding sites and 93% decrease in agonist-stimulated GTPase activity, while the EC antisera had minimal effect (12%). These results indicate that Gi alpha 2 mediates most of the EDRF released via the alpha 2-adrenergic receptor.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology*
  • Amino Acid Sequence
  • Animals
  • Aorta / drug effects
  • Aorta / physiology
  • Binding, Competitive
  • Brimonidine Tartrate
  • Cattle
  • Cells, Cultured
  • Endothelium, Vascular / metabolism*
  • Epinephrine / pharmacology*
  • GTP Phosphohydrolases / metabolism
  • GTP-Binding Proteins / analysis
  • GTP-Binding Proteins / isolation & purification
  • GTP-Binding Proteins / metabolism*
  • Guanylyl Imidodiphosphate / pharmacology
  • Immune Sera
  • Kinetics
  • Molecular Sequence Data
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiology*
  • NAD / metabolism
  • Nitric Oxide / biosynthesis*
  • Nitric Oxide / metabolism
  • Oligopeptides / chemical synthesis
  • Oligopeptides / immunology
  • Pertussis Toxin
  • Quinoxalines / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adrenergic, alpha / drug effects
  • Receptors, Adrenergic, alpha / physiology*
  • Virulence Factors, Bordetella / metabolism
  • Virulence Factors, Bordetella / pharmacology
  • Yohimbine / metabolism

Substances

  • Adrenergic alpha-Agonists
  • Immune Sera
  • Oligopeptides
  • Quinoxalines
  • Receptors, Adrenergic, alpha
  • Virulence Factors, Bordetella
  • NAD
  • Yohimbine
  • Nitric Oxide
  • Guanylyl Imidodiphosphate
  • Brimonidine Tartrate
  • Pertussis Toxin
  • GTP Phosphohydrolases
  • GTP-Binding Proteins
  • Epinephrine